NCT06732492
- Conditions
- CART Therapy, CD7-positive Relapsed/Refractory Lymphoid Hematologic Malignancies, Lymphoma, +6 more
- Locations
-
- Union Hospital Wuhan, Hubei, China
Clinical trial condition
CD7-positive Relapsed/Refractory Lymphoid Hematologic Malignancies
Explore clinical trials studying CD7-positive Relapsed/Refractory Lymphoid Hematologic Malignancies. Study availability and eligibility vary by location and protocol.
1 public trial
1 recruiting study